Healthcare provider profile · identity verified

Ralph Parker Eccles, D.O

Family Practice · KLAMATH FALLS, OR · NPI 1659304459

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	207	63
Atorvastatin Calcium	Atorvastatin Calcium	193	52
Gabapentin	Gabapentin	150	32
Jardiance	Empagliflozin	137	48
Lisinopril	Lisinopril	133	39
Pioglitazone Hcl	Pioglitazone Hcl	129	37
Ozempic	Semaglutide	124	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	123	28
Tamsulosin Hcl	Tamsulosin Hcl	115	23
Amlodipine Besylate	Amlodipine Besylate	99	32
Metformin Hcl	Metformin Hcl	98	29
Levothyroxine Sodium	Levothyroxine Sodium	95	27
Duloxetine Hcl	Duloxetine Hcl	93	22
Famotidine	Famotidine	72	23
Meloxicam	Meloxicam	72	32
Omeprazole	Omeprazole	67	22
Carvedilol	Carvedilol	66	16
Trazodone Hcl	Trazodone Hcl	59	19
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	57	22
Pantoprazole Sodium	Pantoprazole Sodium	56	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	11
Furosemide	Furosemide	47	20
Albuterol Sulfate Hfa	Albuterol Sulfate	46	21
Finasteride	Finasteride	43	13
Oxycodone Hcl	Oxycodone Hcl	43	12
Metoprolol Tartrate	Metoprolol Tartrate	42	11
Eliquis	Apixaban	41	14
Hydrochlorothiazide	Hydrochlorothiazide	41	11
Simvastatin	Simvastatin	41	12
Rosuvastatin Calcium	Rosuvastatin Calcium	40	14
Celecoxib	Celecoxib	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	36	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Allopurinol	Allopurinol	34	suppressed
Metoprolol Succinate	Metoprolol Succinate	34	suppressed
Ventolin Hfa	Albuterol Sulfate	34	11
Farxiga	Dapagliflozin Propanediol	32	12
Montelukast Sodium	Montelukast Sodium	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	28	21
Xarelto	Rivaroxaban	25	suppressed
Baclofen	Baclofen	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Pregabalin	Pregabalin	23	11
Trueplus Pen Needle	Pen Needle, Diabetic	22	13
Trulicity	Dulaglutide	22	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Varenicline Tartrate	Varenicline Tartrate	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Rezvoglar Kwikpen	Insulin Glargine-Aglr	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Donepezil Hcl Odt	Donepezil Hcl	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Primidone	Primidone	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Sertraline Hcl	Sertraline Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error